Monte Rosa Therapeutics
GLUE
GLUE
81 hedge funds and large institutions have $264M invested in Monte Rosa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 11 reducing their positions, and 7 closing their positions.
Holders
81
Holders Change
+7
Holders Change %
+9.46%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
41
Reduced
11
Closed
7
Calls
$895K
Puts
$165K
Net Calls
+$730K
Net Calls Change
+$445K
Top Buyers
1 |
ACA
1
Avoro Capital Advisors
New York
|
$30.7M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$35M |
3 |
3
BlackRock
New York
|
$15.4M |
4 |
PL
4
Parkwood LLC
Cleveland,
Ohio
|
$2.26M |
5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$1.65M |